Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Why is heart failure so common among Hispanic patients? Researchers receive $5.2M to test a new theory

The group will examine data from approximately 1,600 patients, focusing on the relationship between the heart and the aorta. 

CorPath GRX System siemens

Corindus, acquired back in 2019, is now Siemens Healthineers Endovascular Robotics

The company's most well-known product within the industry is the CorPath GRX System, a second-generation robotics solution used by interventional cardiologists during PCI and other interventional procedures.

Juan Granada discusses new cardiac technology AHA22.

VIDEO: 2 key technologies to rapidly advance cardiovascular care

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.

A stack deep silicon photon counting CT detector components. The University of Wisconsin is working with GE Healthcare to develop the new PCD technology. The system and the deep silicon technology was unveiled at RSNA 2022. #RSNA22 #PCCT

VIDEO: Photon-counting CT development at the University of Wisconsin

Tim Szczykutowicz, PhD, DABR, associate professor of radiology at the University of Wisconsin-Madison, is helping develop a new type of photon-counting CT detector that was shown as a work-in-progress by GE Healthcare at RSNA 2022.

Boston Scientific to acquire majority stake of interventional device company for $523M

Acotec, founded in 2008, designs and distributes a wide range of medical devices used in interventional cardiology, including drug-coated balloons and thrombus aspiration catheters.

New risk score helps identify high-risk PCI patients

The risk assessment tool could help health systems and researchers alike determine when patients face greater odds of post-PCI complications. 

Thumbnail

AI-powered platform for heart failure detection gains FDA clearance

According to data submitted to the FDA, the platform has been linked to an accuracy of 90%, sensitivity of 87.8% and specificity of 83%.

Interventional cardiology to join the Match in 2025

It is an announcement many interventional cardiologists have been waiting to hear for a long time.